1145. Deputy Louise O'Reilly asked the Minister for Health the number of drugs which, following the NCPE assessment of the manufacturer's economic dossier on the cost effectiveness of a drug, the NCPE found not to be cost effective; if this information will be provided for each of the past two years with a breakdown of whether additional price reductions were successfully negotiated and agreed upon; and if he will make a statement on the matter. [1168/17]

Summary

1145. Deputy Louise O'Reilly asked the Minister for Health the number of drugs which, following the NCPE assessment of the manufacturer's economic dossier on the cost effectiveness of a drug, the NCPE found not to be cost effective; if this information will be provided for each of the past two years with a breakdown of whether additional price reductions were successfully negotiated and agreed upon; and if he will make a statement on the matter. [1168/17]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 17 January 2017

   Medicinal Products Prices

   1145. Deputy Louise O'Reilly asked the Minister for Health the number of drugs which, following the NCPE assessment of the manufacturer's economic dossier on the cost effectiveness of a drug, the NCPE found not to be cost effective; if this information will be provided for each of the past two years with a breakdown of whether additional price reductions were successfully negotiated and agreed upon; and if he will make a statement on the matter. [1168/17]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Prices

  xml · EN · 17 January 2017

  ViewDownloadOpen at official source

Sponsors

• O'Reilly, Louise. · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.